BioMarin· @BioMarin · X·· 2026-05-21精选AI 评分62
AI 导读
BioMarin宣布其针对儿童软骨发育不全症（hypochondroplasia）的3期关键研究取得阳性顶线结果。软骨发育不全症是一种遗传性骨骼疾病，目前尚无获批疗法，公司称该结果是为满足这一患者群体未满足需求迈出的重要一步。
推荐理由
BioMarin公布软骨发育不全症3期关键研究阳性顶线结果，该病目前尚无获批疗法，读者可了解这一罕见骨骼疾病的研发进展。
正文
Today we announced positive topline results from a Phase 3 pivotal study in children with hypochondroplasia, a genetic skeletal condition for which there are currently no approved treatments.
The results mark an important step toward addressing the unmet needs of children living with hypochondroplasia.
Learn more: http://ms.spr.ly/6017vp0dh
来源：BioMarin · x.com